Home / Stocks / ARTV

ARTV insider trading

Artiva Biotherapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
11
Bought · 24 mo
$109.2M
Buys · last 90 days
9 · $17.7M
Most recent buy
2026-07-31

Cluster buy detected

3 insiders bought ARTV within a short window (2026-05-11→2026-07-10), $104.2M in total — cluster score 75/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-31Kolchinsky Peter
Director · 10% owner
Bought45,768$9.96$456k
2026-07-28Kolchinsky Peter
Director · 10% owner
Bought41,319$9.99$413k
2026-07-23Kolchinsky Peter
Director · 10% owner
Bought6,522$8.94$58k
2026-07-23Kolchinsky Peter
Director · 10% owner
Bought264,586$9.76$2.6M
2026-07-20Kolchinsky Peter
Director · 10% owner
Bought160,354$8.93$1.4M
2026-07-14Kolchinsky Petercluster
Director · 10% owner
Bought21,654$8.96$194k
2026-06-29Kolchinsky Petercluster
Director · 10% owner
Bought32,876$8.89$292k
2026-06-16Kolchinsky Petercluster
Director · 10% owner
Bought531,326$8.66$4.6M
2026-06-11Kolchinsky Petercluster
Director · 10% owner
Bought1,027,722$7.44$7.7M
2026-05-28GC Cell Corpcluster
10% owner
Bought1,432,291$11.52$16.5M
2026-05-13Kolchinsky Petercluster
Director · 10% owner
Bought6,510,416$11.52$75.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Kolchinsky PeterDirector · 10% owner10$92.7M
GC Cell Corp10% owner1$16.5M

See ARTV on the chart

Every insider buy and sell for ARTV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.